<p><strong>Treatment of postmenopausal osteoporosis</strong>: Recommended dose is a single intravenous infusion of 5 mg Zoledronic Acid administered once a year. Adequate supplemental Calcium and Vitamin-D intake is important in women with osteoporosis if dietary intake is inadequate.&nbsp;<br />
<br />
<strong>Prevention of clinical fractures after a hip fracture</strong>: Recommended dose is a single intravenous infusion of 5 mg Zoledronic Acid&nbsp;administered once a year. In patients with a recent low-trauma hip fracture, it is recommended to give the first Zoledronic Acid solution for infusion two or more weeks after hip fracture repairs. It is also recommended to have a loading dose of 50,000 to 125,000 IU of Vitamin-D given orally or via intramuscular route prior to the first administration of Zoledronic Acid solution for infusion. Supplemental Calcium and Vitamin-D intake is recommended for patients treated to prevent clinical fractures after a hip fracture.<br />
<br />
<strong>Treatment of osteoporosis in men</strong>: Recommended dose is a single intravenous infusion of 5 mg Zoledronic Acid administered once a year. Adequate supplemental Calcium and Vitamin-D intake is important in men with osteoporosis if dietary intake is inadequate.&nbsp;<br />
<br />
<strong>Treatment and prevention of glucocorticoid-induced osteoporosis</strong>: Recommended dose is a single intravenous infusion of 5 mg Zoledronic Acid administered once a year. Adequate supplemental Calcium and Vitamin-D intake is important in patients with osteoporosis if dietary intake is inadequate.<br />
<br />
<strong>Treatment of paget&#39;s disease of bone</strong>: Recommended dose is a single intravenous infusion of 5 mg Zoledronic Acid. Re-treatment with Zoledronic Acid may be considered in patients who have relapsed, based on increases in serum alkaline phosphatase, in patients who failed to achieve normalization of serum alkaline phosphatase, or in patients with symptoms, as dictated by medical practice 12 months after the initial dose.<br />
<br />
In patients with paget&#39;s disease, adequate Vitamin-D intake is recommended in association with Zoledronic Acid administration. In addition, it is strongly advised that adequate supplemental Calcium corresponding to at least 500 mg elemental Calcium twice daily is ensured in patients with paget&#39;s disease for at least 10 days following Zoledronic Acid administration.</p>

<p>&nbsp;</p>

<p><strong>Administration</strong></p>

<p>The dose of 5 mg Zoledronic acid must be administered over at least 15 minutes. Zoledronic Acid&nbsp;should be administered intravenously via a infusion line, given at a constant infusion rate. The infusion time must not be less than 15 minutes.</p>